Invited review Novel vaccines against Theileria parva: prospects for sustainability
A first-gneration subunit vaccine for East Coast fever based on the Theileria parva p67 sporozoite surface antigen is entering preliminary field trials. Intensive efforts are also focused on the identification of a schizont-specific omponen for incorporation in a second-generation multi-component pr...
| Main Authors: | , |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
Elsevier
1998
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/32963 |
Similar Items: Invited review Novel vaccines against Theileria parva: prospects for sustainability
- Conservation of the sporozoite p67 vaccine antigen in cattle-derived Theileria parva stocks with different cross-immunity profiles
- Multi-component subunit vaccines against Theileria parva
- Theileria parva sporozoite invasion and development within bovine dendritic cells
- Vaccines against Theileria parva
- Vaccines against Theileria parva
- Experiences with immunization against Theileria parva using p67, a sporozoite surface antigen